Skip to main content
Equibles

Roger Song

Analyst

Kavasimika Biotech

Equibles does not estimate personal net worth.

About Roger Song

Roger Song is recorded as Analyst at Kavasimika Biotech. Roger Song has spoken on 1 investor event across 1 company, most recently for Nektar Therapeutics on June 3, 2026. The companies whose calls Roger Song spoke on are classified in the Healthcare sector.

Roger Song on recent calls

“It's my pleasure to have our next company doing the Fireside Nectar Therapeutics, and then we have JD with me.”
Analyst — Kavasimika Biotech, 2026 Jefferies Global Healthcare Conference ·

Affiliation history

  • Kavasimika Biotech

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity